Why the study?
Does varying doses of hydrochlorothiazide affect arterial elasticity and metabolic parameters in hypertensive patients with and without glucose intolerance?
Does varying doses of hydrochlorothiazide affect arterial elasticity and metabolic parameters in hypertensive patients with and without glucose intolerance?
Low-dose HCTZ improves arterial elasticity in uncomplicated hypertension, but higher doses worsen glucose metabolism without providing additional vascular or blood pressure benefits.
May favor low-dose HCTZ for arterial elasticity in uncomplicated hypertension; hypothesis-generating for dose effects in diabetes or impaired fasting glucose.
Thiazide diuretics may cause multiple metabolic abnormalities. The authors investigated the effects of varying doses of hydrochlorothiazide (HCTZ) on arterial elasticity and metabolic parameters in patients with hypertension (HTN), HTN and impaired fasting glucose (HTN+IFG), and HTN and type 2 diabetes mellitus (HTN+DM). The patients received low and high doses of HCTZ. Systolic and diastolic blood pressures declined significantly during the first 3 months in all patients, but no additional decrease was seen following the increase in HCTZ dose. In HTN, large artery elasticity index and small artery elasticity increased during the study. In HTN+IFG, large artery elasticity index increased without improvement in small artery elasticity index. In HTN+DM, both large artery elasticity index and small artery elasticity index did not improve during follow-up. Low-dose HCTZ improves arterial elasticity in hypertensive patients, but this effect is diminished with concomitant DM or IFG. The HCTZ dose increase worsened parameters of glucose metabolism and did not further decrease blood pressure or improve arterial elasticity.
No takes yet. Share an insight, caveat, or question.
Shargorodsky et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: